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Abstract
BACKGROUND: Anaphylaxis is a systemic hypersensitivity reaction marked by life-threatening, rapid onset of the 
airway, breathing, and circulation problems. Despite its rare incidence, without proper treatment, it may cause fatality. 
CASE REPORT: In this report, we present a 19-year-old female with an infected ovarian cyst, who was scheduled for 
gynecologic laparotomy. In pre-operative assessment, she was classified as an American Society of Anesthesiologist 
(ASA) one patient without any history of drug or food allergy. Hemodynamic changes occurred on anesthesia 
induction after the administration ofatracurium, a muscle relaxant agent. Marked clinical signs were wheezed-
bronchospasm, dyspnea, hypersalivation, desaturation, tachycardia, hypotension, and systemic erythema. She was 
diagnosed with anaphylactic shock. We provided 100% oxygenation, fluid resuscitation, epinephrine, and supportive 
therapy by anaphylaxis guidelines. Respiratory and cardiovascular functions stabilized 2 h post-resuscitation. The 
surgery was canceled, and she was observed in ICU for 24 h. 
CONCLUSION: Timely diagnosis and early resuscitation are key factors determining the outcome of an anaphylactic 
reaction.
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Introduction
Anaphylaxis is a severe, life-threatening 
systemic hypersensitivity reaction that is characterized 
by the emergence of life-threatening airway, respiratory, 
and circulatory problems with rapid onset and is usually 
associated with changes in the skin and mucosa [1]. Its 
prevalence ranges from 1:3,500 to 1:13,000 [2]. Overall, 
anaphylaxis has a good prognosis, with a case fatality 
ratio of <1%. The risk of death is increased in patients 
with asthma, especially in uncontrolled asthma [3].
Anaphylactic reactions are generally 
unpredictable allergic reactions, which occur very 
quickly, which can arise especially during surgery 
due to varying drug administration. The diagnosis of 
anaphylaxis in the perioperative period is still a challenge 
for the anesthesiologist. A study reported that of the 42 
anesthesia teams tested by simulators, none was able 
to identify anaphylaxis in the first 10 min. [2], [4].
Case Illustration
A 19-year-old woman, 55 kg, was planned 
for laparotomy surgery due to an infected left ovarian 
cyst. A day before the surgery, detailed history, physical 
examinations, and investigations were carried out. There 
was no history of allergy to drugs or food, no history of 
asthma, and no history of the previous surgery. There 
were no marked abnormalities in physical or supporting 
examinations.
She was planned for general anesthesia with 
the insertion of the orotracheal tube. She received 
cefotaxime 1 g and metronidazole 500 mg as 
prophylactic antibiotics an hour before surgery and 
was premedicated with dexamethasone 5 mg and 
midazolam 2 mg. After induction with 75 mcg fentanyl 
and 100 mg propofol intravenously, she still showed 
stable hemodynamic conditions. To facilitate intubation, 
we administered intravenous atracurium 25 mg. 
One minute after the administration of atracurium, 
we noticed hypersecretion in her airway. She then 
developed wheezing sounds and difficulty to ventilate 
the airway. Saturation was decreased to 80% despite 
100% O2 being given, followed by marked erythema 
developed in most parts of the skin, hypotension (BP 
67/33 mmHg), and tachycardia (HR 134–138 bpm).
Anaphylaxis shock was diagnosed. We 
immediately performed intubation to maintain the airway 
– positive pressure ventilation with 100% FiO2 oxygen. 
Epinephrine 0.5 mg was given intramuscularly, and 
dexamethasone 5 mg was administered intravenously. 
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An hour later, all parameters were improved. We decided 
to cancel the surgery. We obtained blood sample for the 
IgE test on intensive care unit (ICU) admission, which 
returned increased. As she regains consciousness, she 
was extubated and sent to ICU for 24 h of observation 
before finally being transferred to the inpatient ward. 
She was discharged on the 4th day after the event.
The patient was rescheduled for surgery 
4 weeks after the event. We used vecuronium as an 
alternative muscle relaxant for this case. The surgery 
went uneventful, and the patient was then relieved from 
her previous condition.
Discussion
The term anaphylaxis comes from the word 
“ana” which means opposite and “phylaxis” which 
means protection. This term was coined by Portier 
and Richet in 1902 to describe the adverse reactions 
that occur after repeated exposure to foreign proteins, 
rather than immunization or prophylaxis as expected. 
Anaphylaxis generally occurs after repeated exposure 
to a specific antigen, and the release of inflammatory 
mediators occurs. However, anaphylactic reactions can 
occur in the first exposure to a product or drug due to a 
cross-reaction. [2], [5].
Anaphylactoid reactions (also called non-
immune anaphylaxis) are different from anaphylaxis 
because they occur through the process of releasing 
inflammatory mediators directly without mediating 
immunoglobulins or through complement activation. 
However, both have the same clinical manifestations [2].
The clinical manifestations of anaphylaxis 
occur due to the release of chemical mediators from 
mast cells and basophils. In susceptible individuals, the 
first exposure to an antigen will trigger IgE production 
which will bind to mast cells and basophils. On repeated 
exposure, the antigen will cross with two IgE receptors 
which will then induce tyrosine phosphorylation by Lyn 
and Syk tyrosine kinases. This process initiates a series 
of signal transduction which leads to an increase in 
intracellular calcium levels and the release of mediators 
such as histamine, protease, proteoglycans, and platelet-
activating factors. Phospholipid metabolism in the next 
process will produce leukotrienes and prostaglandins. 
Histamine, leukotrienes, and prostaglandins are 
vasoactive mediators that play a role in changes in 
vascular permeability, flushing, urticaria, angioedema, 
hypotension, and bronchoconstriction.
The diagnosis of anaphylaxis in the perioperative 
period presents its challenges. In this period, the patient 
is generally covered by sterile cloth and is typically 
unconscious or sedated so that signs of anaphylaxis can 
only be identified by bronchospasm and cardiovascular 
dysfunction. Unfortunately, these manifestations can also 
occur due to anesthesia. The severity of anaphylactic 
reactions can vary from mucocutaneous abnormalities 
that occur thoroughly to cardiac arrest [2], [6].
The diagnosis of anaphylaxis is based on the 
clinical manifestations. The supportive examination is 
not beneficial in acute conditions because it takes time 
and may give false negative results [5]. In our case, the 
patient experienced a disorder that occurs rapidly after 
the intravenous administration of atracurium. The first 
manifestation is respiratory abnormalities in the form of 
wheezing and increased airway pressure followed by 
skin redness and cardiovascular system disorders such 
as tachycardia and hypotension.
The goal of anaphylactic management is to 
stop exposure to precipitating agents, reduce the effects 
of detached mediators, and prevent the production and 
release of further mediators. Epinephrine is the drug 
of choice for anaphylaxis. Epinephrine has an α-1 
adrenergic vasoconstrictor effect in almost all organ 
systems and can relieve airway obstruction due to 
mucosal edema and prevent and overcome shock.
Furthermore, epinephrine is an agonist for β-1 
and β-2 adrenergic receptors [6]. Effects on β-adrenergic 
receptors provide positive bronchodilator, inotropic, and 
chronotropic effects [7]. The recommended method of 
administration is intramuscular injection. This injection 
technique allows faster onset than the subcutaneous. 
Intravenous administration of epinephrine can be 
applied to exceptional conditions such as severe 
hypotension, cardiac arrest, or respiratory arrest, or 
if multiple doses of intramuscular epinephrine do not 
produce satisfactory results [8].
The patients who experience anaphylaxis 
should be positioned supine by lifting the inferior limb 
to maintain adequate fluid in the intravascular space. 
In anaphylaxis, the patients are susceptible to large 
numbers of intravascular fluid losses that move to the 
interstitial space so that in addition to the position, it is 
necessary to administer saline fluid quickly with a good 
monitoring to avoid excess fluid.
The administration of antihistamines and 
glucocorticoids should not replace the position of 
epinephrine as the drug of choice [9]. The time of 
antihistamine onset and the time needed to reach the 
peak of concentration is longer.
Selective β-2 adrenergic agonists are 
sometimes given anaphylaxis as an adjunct therapy to 
treat wheezing, coughing, or shortness of breath that 
does not improve with epinephrine. Although beneficial 
for the lower respiratory tract, this drug should not 
replace epinephrine as a first-line drug.
Endotracheal intubation, if needed, should be 
carried out by the most experienced personnel available. 
In anaphylaxis, it can be difficult to recognize the 
anatomical structure of the upper airway due to swelling 
of the oropharynx’s tongue and mucosa, excessive 
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mucous secretion, or due to angioedema. This condition 
will complicate the insertion of endotracheal tubes [10]. 
It should be noted that oxygenation is more critical than 
intubation. It is best to choose the most accessible and 
most available oxygenation technique.
Conclusion
Anaphylaxis in the perioperative period is a 
challenge for anesthesiologists due to the use of several 
types of drugs at almost the same time. Therefore, 
an anesthesiologist must be equipped with proper 
knowledge and skills and has a high awareness of 
anaphylaxis because early diagnosis and appropriate 
therapy determine patient safety.
Acknowledgment
The authors report no conflicts of interest.
References
1. Tupper J, Visser S. Anaphylaxis: A review and update. Can Fam 
Physician. 2010;56(10):1009-11.
 PMid:20944042
2. Patel TK, Patel PB, Barvaliya MJ, Tripathi CB. Drug-induced 
anaphylactic reactions in Indian population: A systematic 
review. Indian J Crit Care Med. 2014;18(12):796-806. https://
doi.org/10.4103/0972-5229.146313
 PMid:25538414
3. Kmet A, Unger J, Jahangir K, Kolber MR. Fish-oil capsule 
ingestion: A case of recurrent anaphylaxis. Can Fam Phys. 
2012;58(7):e379-81.
 PMid:22798474
4. Kannan JA, Bernstein JA. Perioperative anaphylaxis: Diagnosis, 
evaluation, and management. Immunol Allergy Clin North Am. 
2015;35(2):321-34.
 PMid:25841554
5. Sadleir PH, Clarke RC, Bunning DL, Platt PR. Anaphylaxis 
to neuromuscular blocking drugs: Incidence and cross-
reactivity in Western Australia from 2002 to 2011. Br J Anaesth. 
2013;110:981-7. https://doi.org/10.1093/bja/aes506
 PMid:23335568
6. Rudders SA, Banerji A, Corel B, Clark S, Carargo CA Jr. 
Multicenter study of repeat epinephrine treatments for food-
related anaphylaxis. Pediatrics. 2010;125(4):e711-8. https://doi.
org/10.1542/peds.2009-2832
 PMid:20308215
7. Kanwar M, Irvin CB, Frank JJ, Weber K, Rosman H. Confusion 
about epinephrine dosing leading to iatrogenic overdose: 
A life-threatening problem with a potential solution. Ann 
Emerg Med. 2010;55(4):341-4. https://doi.org/10.1016/j.
annemergmed.2009.11.008
 PMid:20031267
8. Link MS, Berkow LC, Kudenchuk PJ, Halperin HR, Hess EP, 
Moitra VK, et al. Part 7: Adult advanced cardiovascular life 
support: 2015 American heart association guidelines update for 
cardiopulmonary resuscitation and emergency cardiovascular 
care. Circulation. 2015;132(Suppl 2):S444-64. https://doi.
org/10.1161/cir.0000000000000261
 PMid:26472995
9. Simons FE, Ardusso LR, Dimov V, Ebisawa M, El-Gamal YM, 
Lockey RF, et al. World allergy organization anaphylaxis 
guidelines: 2013 Update of the evidence base. Int Arch Allergy 
Immunol. 2013;162:193-204. https://doi.org/10.1159/000354543
 PMid:24008815
10. Wechsler JB, Schroeder HA, Byrne AJ, Chien KB, Bryce PJ. 
Anaphylactic responses to histamine in mice utilize both 
histamine receptors 1 and 2. Allergy. 2013;68(10):1338-40. 
https://doi.org/10.1111/all.12227
 PMid:24112077
